Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Monash University
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00588705
First received: December 24, 2007
Last updated: October 16, 2014
Last verified: October 2014

December 24, 2007
October 16, 2014
December 2007
December 2015   (final data collection date for primary outcome measure)
Is a demonstration of the effectiveness of the module in changing the behavior of clinicians after taking part in the communication skills module. [ Time Frame: conclusion of study ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00588705 on ClinicalTrials.gov Archive Site
To examine the views of women about the provision of genetic risk information to their daughters. [ Time Frame: conclusion of study ] [ Designated as safety issue: No ]
Not Provided
Not Provided
Not Provided
 
The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer
The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters.

A second part of the study asks women for their opinions about when and how their daughters should be told about any genetic risks.

All of this will help us develop teaching methods to help our doctors improve the way they talk about genetic risk when women with breast cancer have adolescent daughters.

Not Provided
Observational
Observational Model: Family-Based
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Memorial Sloan-Kettering Cancer Center (MSK) breast cancer patients seen by the clinical genetics service (CGS)and their daughters

  • Breast Cancer
  • Counseling
Behavioral: focus group & questionaire
The focus group will last about 90 minutes. However, your involvement in this study will last from the time you join until you read over the summary of what happened during the focus group and return your comments. This should be approximately 2 months. Patient will complete a questionnaire and we estimate total time for completion to be approximately 7 minutes.
focus group & questionaire
The group will discuss its views about how and when to talk about the risk of getting breast cancer. The focus group will be video recorded and the video recorded material will be later transcribed and carefully analyzed. In addition you will be asked to answer questions about yourself, such as education and marital status.
Intervention: Behavioral: focus group & questionaire
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
27
December 2015
December 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women seen in the MSK CGS Service who have a diagnosis of breast cancer or
  • a family history of breast cancer and
  • have biological daughter(s) in the age range 12-20 years will be eligible to participate in Phase I & II.
  • Women who were consented to Phase I will automatically be eligible for Phase II.

Exclusion Criteria:

  • Women seen in the MSK CGS Service will be ineligible if they have no diagnosis of breast cancer and no family history of breast cancer,
  • do not have a biological daughter,
  • or have a biological daughter fewer than 12 or greater than 20 years(unless they were consented to Phase 1).
  • Women will be ineligible if they are not English speaking,
  • have intellectual or cognitive impairment,
  • or active mental illness rendering them incapable of giving informed consent, such as might occur with active psychosis.
Female
12 Years to 20 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00588705
07-063
Not Provided
Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
Monash University
Principal Investigator: Smita Banerjee, PhD Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
October 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP